Related Experiment Video
Updated: Dec 23, 2025
Implantation and Evaluation of Melanoma in the Murine Choroid via Optical Coherence Tomography
Published on: December 2, 2022
Effect of oncolytic ECHO-7 virus strain Rigvir on uveal melanoma cell lines
Andra Tilgase1, Lita Grīne2, Ilze Blāķe2
1Rigvir, Atlasa iela 7C, LV-1026, Riga, Latvia. andra.tilgase@rigvir.com.
Objective:
Uveal melanoma is a rare intraocular malignancy. Half of the patients diagnosed will develop metastases within 10 to 30 years, most commonly in the liver. Although there has been a significant development in the treatment of melanoma, no effective treatment to prevent or treat metastases of uveal melanoma is available. Oncolytic viruses are now being studied for various types of cancers and show promising results. Preclinical results show cytolytic activity of enteric cytopathic human orphan virus type 7 (ECHO-7) strain Rigvir in human melanoma, rhabdomyosarcoma, gastric adenocarcinoma, lung carcinoma and pancreas adenocarcinoma cell lines. The aim of this study was to test the possible cytolytic activity in human uveal melanoma cell lines.
Results:
The results suggest cytolytic activity of oncolytic ECHO-7 virus strain Rigvir in MP41, 92-1 and Mel-202 cell lines.
Insights
Oncolytic ECHO-7 virus strain Rigvir shows cytolytic activity against uveal melanoma cell lines. This finding offers potential for new treatments for this rare eye cancer and its metastases.
Area of Science:
- Oncology
- Virology
- Ophthalmology
Background:
- Uveal melanoma is a rare intraocular cancer with a high risk of metastasis.
- Current treatments for uveal melanoma metastases are limited.
- Oncolytic viruses are emerging as a potential cancer therapy.
Purpose of the Study:
- To investigate the cytolytic activity of enteric cytopathic human orphan virus type 7 (ECHO-7) strain Rigvir.
- To evaluate ECHO-7 Rigvir's efficacy in human uveal melanoma cell lines.
Main Methods:
- Testing the cytolytic activity of ECHO-7 Rigvir.
- Utilizing human uveal melanoma cell lines (MP41, 92-1, Mel-202).
Main Results:
- ECHO-7 virus strain Rigvir demonstrated cytolytic activity.
- Activity was observed in MP41, 92-1, and Mel-202 uveal melanoma cell lines.
Conclusions:
- Oncolytic ECHO-7 virus strain Rigvir exhibits potential as a therapeutic agent for uveal melanoma.
- Further research is warranted to explore its application in treating uveal melanoma and its metastases.
